International Lung Cancer Summit shared a post on LinkedIn:
“Five-year survival in small cell lung cancer: once unimaginable, now 12%.
At ILCS 2025, Dr. Rami Manochakian reviewed how adding IO to platinum–etoposide (as shown in IMpower133 and CASPIAN) has changed practice, bringing modest OS gains but meaningful long-term survivors.
With data from IMbrella A by Stephen Liu and Martin Reck, the story of SCLC is slowly evolving.
Proceed to the video attached to the post.
More posts featuring International Lung Cancer Summit.